印度制药大会旨在促进创新和高价值制造. India's pharma conference aims to boost innovation and high-value drug manufacturing.

印度第九届药物制造大会将推动药品创新,特别是生物制剂的发展. The 9th India Pharma Conference in New Delhi will advance drug innovation, particularly biologicals, aiming to shift India from generic manufacturing to high-value, globally competitive medicines. 医药部和FICCI组织的这次活动将于2026年4月13日至14日举行, 将包括与卫生部长举行的圆桌会议以及加强药物发现生态系统的讨论. Scheduled for April 13–14, 2026, the event, organized by the Department of Pharmaceuticals and FICCI, will include a roundtable with the Health Minister and sessions on strengthening the drug discovery ecosystem. 通过CDSCO简化监管流程, 加快批准时间表,鼓励政府,工业界,学术界和创业公司之间合作以促进创新, 并将印度定位为药物开发的全球中心. A key focus is streamlining regulatory processes through the CDSCO to accelerate approval timelines, encouraging collaboration among government, industry, academia, and startups to boost innovation and position India as a global hub for drug development.